Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case-control matched multicenter study (BACTCOVID)

Viral Infections, Non-HIV

Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study

Int J Med Sci.

Pan F, Yang L, Li Y, Liang B, Li L, Ye T, Li L, Liu D, Gui S, Hu Y, Zheng C

doi: 10.7150/ijms.46614.

Bacterial Infections

A prospective, multicenter, and non-interventional case control study about the risk factors associated to acquisition and mortality of Enterobacter species bacteremia

J Infect.

Álvarez-Marín R, Navarro-Amuedo D, Gasch-Blasi O, Rodríguez-Martínez JM, Calvo-Montes J, Lara-Contreras R, Lepe-Jiménez JA, Tubau-Quintano F, Cano-García ME, Rodríguez-López F, Rodríguez-Baño J, Pujol-Rojo M, Torre-Cisneros J, Martínez-Martínez L, Pascual-Hernández Á, Mejías MEJ, Spanish Network for Research in Infectious Diseases/Enterobacter spp. Bacteriemia Project group.

doi: 10.1016/j.jinf.2019.09.017.

Viral Infections, Non-HIV

Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China

Ann Oncol.

Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, Jia P, Guan HQ, Peng L, Chen Y, Peng P, Zhang P, Chu Q, Shen Q, Wang Y, Xu SY, Zhao JP, Zhou M

doi: 10.1016/j.annonc.2020.03.296.

Viral Infections, Non-HIV

Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study

Clin Microbiol Infect.

Nachtigall I, Lenga P, Jóźwiak K, Thürmann P, Meier-Hellmann A, Kuhlen R, Brederlau J, Bauer T, Tebbenjohanns J, Schwegmann K, Hauptmann M, Dengler J

doi: 10.1016/j.cmi.2020.08.011.

Viral Infections, Non-HIV

Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicenter study

Clin Microbiol Infect.

Bartoletti M, Marconi L, Scudeller L, Pancaldi L, Tedeschi S, Giannella M, Rinaldi M, Bussini L, Valentini I, Ferravante AF, Potalivo A, Marchionni E, Fornaro G, Pascale R, Pasquini Z, Puoti M, Merli M, Barchiesi F, Volpato F, Rubin A, Saracino A, Tonetti T, Gaibani P, Ranieri VM, Viale P, Cristini F, PREDICO study group.

doi: 10.1016/j.cmi.2020.09.014.

Viral Infections, Non-HIV

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Trials.

Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Bond S, Hernan-Sancho E, Norton S, Cheriyan J, Cope A, Galloway J, Hall F, Jayne D, Wilkinson IB

doi: 10.1186/s13063-020-04535-4.

Viral Infections, Non-HIV

Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

Infect Dis Ther

Ruiz-Antorán B, Sancho-López A, Torres F, Moreno-Torres V, de Pablo-López I, García-López P, Abad-Santos F, Rosso-Fernández CM, Aldea-Perona A, Montané E, Aparicio-Hernández RM, Llop-Rius R, Pedrós C, Gijón P, Hernández-Carballo C, Pedrosa-Martínez MJ, Rodríguez-Jiménez C, Prada-Ramallal G, Cabrera-García L, Aguilar-García JA, Sanjuan-Jimenez R, Ortiz-Barraza EI, Sánchez-Chica E, Fernández-Cruz A, TOCICOV-study group.

doi: 10.1007/s40121-020-00373-8

Bacterial Infections

Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study

Antimicrob Resist Infect Control.

Segagni Lusignani L, Presterl E, Zatorska B, Van den Nest M, Diab-Elschahawi M

doi: 10.1186/s13756-019-0668-2.

Viral Infections, Non-HIV

Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study

Swiss Med Wkly

Maximiano Sousa F, Roelens M, Fricker B, Thiabaud A, Iten A, Cusini A, Flury D, Buettcher M, Zukol F, Balmelli C, Zimmermann P, Troillet N, Vuichard-Gysin D, Schreiber PW, Bernhard-Stirnemann S, Tschudin-Sutter S, Nussbaumer-Ochsner Y, Sommerstein R, Gaudenz R, Marschall J, Senn L, Gardiol C, Keiser O, Schüpbach G, Wymann M, Vidondo B, Ch-Sur Study Group

doi: 10.4414/smw.2021.20547

Related content

Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study

A prospective, multicenter, and non-interventional case control study about the risk factors associated to acquisition and mortality of Enterobacter species bacteremia

Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China

Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study

Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicenter study

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study

Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study